{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T00:29:25Z","timestamp":1786667365627,"version":"build-2736575974"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T00:00:00Z","timestamp":1780963200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T00:00:00Z","timestamp":1786665600000},"content-version":"vor","delay-in-days":66,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["ANR-10-COHO-0004"],"award-info":[{"award-number":["ANR-10-COHO-0004"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["ANR-10-COHO-0004"],"award-info":[{"award-number":["ANR-10-COHO-0004"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["ANR-10-COHO-0004"],"award-info":[{"award-number":["ANR-10-COHO-0004"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["ANR-10-COHO-0004"],"award-info":[{"award-number":["ANR-10-COHO-0004"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["ANR-10-COHO-0004"],"award-info":[{"award-number":["ANR-10-COHO-0004"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["ANR-10-COHO-0004"],"award-info":[{"award-number":["ANR-10-COHO-0004"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["ANR-10-COHO-0004"],"award-info":[{"award-number":["ANR-10-COHO-0004"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["ANR-10-COHO-0004"],"award-info":[{"award-number":["ANR-10-COHO-0004"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["ANR-10-COHO-0004"],"award-info":[{"award-number":["ANR-10-COHO-0004"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["ANR-10-COHO-0004"],"award-info":[{"award-number":["ANR-10-COHO-0004"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["ANR-10-COHO-0004"],"award-info":[{"award-number":["ANR-10-COHO-0004"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["ANR-10-COHO-0004"],"award-info":[{"award-number":["ANR-10-COHO-0004"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["ANR-10-COHO-0004"],"award-info":[{"award-number":["ANR-10-COHO-0004"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["ANR-10-COHO-0004"],"award-info":[{"award-number":["ANR-10-COHO-0004"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["ANR-10-COHO-0004"],"award-info":[{"award-number":["ANR-10-COHO-0004"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["ANR-10-COHO-0004"],"award-info":[{"award-number":["ANR-10-COHO-0004"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006364","name":"Institut National Du Cancer","doi-asserted-by":"publisher","award":["LYriCAN+, INCa-DGOS-INSERM-ITMO cancer_18003"],"award-info":[{"award-number":["LYriCAN+, INCa-DGOS-INSERM-ITMO cancer_18003"]}],"id":[{"id":"10.13039\/501100006364","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006364","name":"Institut National Du Cancer","doi-asserted-by":"publisher","award":["LYriCAN+, INCa-DGOS-INSERM-ITMO cancer_18003"],"award-info":[{"award-number":["LYriCAN+, INCa-DGOS-INSERM-ITMO cancer_18003"]}],"id":[{"id":"10.13039\/501100006364","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006364","name":"Institut National Du Cancer","doi-asserted-by":"publisher","award":["LYriCAN+, INCa-DGOS-INSERM-ITMO cancer_18003"],"award-info":[{"award-number":["LYriCAN+, INCa-DGOS-INSERM-ITMO cancer_18003"]}],"id":[{"id":"10.13039\/501100006364","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006364","name":"Institut National Du Cancer","doi-asserted-by":"publisher","award":["LYriCAN+, INCa-DGOS-INSERM-ITMO cancer_18003"],"award-info":[{"award-number":["LYriCAN+, INCa-DGOS-INSERM-ITMO cancer_18003"]}],"id":[{"id":"10.13039\/501100006364","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006364","name":"Institut National Du Cancer","doi-asserted-by":"publisher","award":["LYriCAN+, INCa-DGOS-INSERM-ITMO cancer_18003"],"award-info":[{"award-number":["LYriCAN+, INCa-DGOS-INSERM-ITMO cancer_18003"]}],"id":[{"id":"10.13039\/501100006364","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006364","name":"Institut National Du Cancer","doi-asserted-by":"publisher","award":["LYriCAN+, INCa-DGOS-INSERM-ITMO cancer_18003"],"award-info":[{"award-number":["LYriCAN+, INCa-DGOS-INSERM-ITMO cancer_18003"]}],"id":[{"id":"10.13039\/501100006364","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006364","name":"Institut National Du Cancer","doi-asserted-by":"publisher","award":["LYriCAN+, INCa-DGOS-INSERM-ITMO cancer_18003"],"award-info":[{"award-number":["LYriCAN+, INCa-DGOS-INSERM-ITMO cancer_18003"]}],"id":[{"id":"10.13039\/501100006364","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006364","name":"Institut National Du Cancer","doi-asserted-by":"publisher","award":["LYriCAN+, INCa-DGOS-INSERM-ITMO cancer_18003"],"award-info":[{"award-number":["LYriCAN+, INCa-DGOS-INSERM-ITMO cancer_18003"]}],"id":[{"id":"10.13039\/501100006364","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006364","name":"Institut National Du Cancer","doi-asserted-by":"publisher","award":["LYriCAN+, INCa-DGOS-INSERM-ITMO cancer_18003"],"award-info":[{"award-number":["LYriCAN+, INCa-DGOS-INSERM-ITMO cancer_18003"]}],"id":[{"id":"10.13039\/501100006364","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006364","name":"Institut National Du Cancer","doi-asserted-by":"publisher","award":["LYriCAN+, INCa-DGOS-INSERM-ITMO cancer_18003"],"award-info":[{"award-number":["LYriCAN+, INCa-DGOS-INSERM-ITMO cancer_18003"]}],"id":[{"id":"10.13039\/501100006364","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006364","name":"Institut National Du Cancer","doi-asserted-by":"publisher","award":["LYriCAN+, INCa-DGOS-INSERM-ITMO cancer_18003"],"award-info":[{"award-number":["LYriCAN+, INCa-DGOS-INSERM-ITMO cancer_18003"]}],"id":[{"id":"10.13039\/501100006364","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006364","name":"Institut National Du Cancer","doi-asserted-by":"publisher","award":["LYriCAN+, INCa-DGOS-INSERM-ITMO cancer_18003"],"award-info":[{"award-number":["LYriCAN+, INCa-DGOS-INSERM-ITMO cancer_18003"]}],"id":[{"id":"10.13039\/501100006364","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006364","name":"Institut National Du Cancer","doi-asserted-by":"publisher","award":["LYriCAN+, INCa-DGOS-INSERM-ITMO cancer_18003"],"award-info":[{"award-number":["LYriCAN+, INCa-DGOS-INSERM-ITMO cancer_18003"]}],"id":[{"id":"10.13039\/501100006364","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006364","name":"Institut National Du Cancer","doi-asserted-by":"publisher","award":["LYriCAN+, INCa-DGOS-INSERM-ITMO cancer_18003"],"award-info":[{"award-number":["LYriCAN+, INCa-DGOS-INSERM-ITMO cancer_18003"]}],"id":[{"id":"10.13039\/501100006364","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006364","name":"Institut National Du Cancer","doi-asserted-by":"publisher","award":["LYriCAN+, INCa-DGOS-INSERM-ITMO cancer_18003"],"award-info":[{"award-number":["LYriCAN+, INCa-DGOS-INSERM-ITMO cancer_18003"]}],"id":[{"id":"10.13039\/501100006364","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006364","name":"Institut National Du Cancer","doi-asserted-by":"publisher","award":["LYriCAN+, INCa-DGOS-INSERM-ITMO cancer_18003"],"award-info":[{"award-number":["LYriCAN+, INCa-DGOS-INSERM-ITMO cancer_18003"]}],"id":[{"id":"10.13039\/501100006364","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Lymphopenia has been associated with poor outcomes in metastatic breast cancer (BC), but its prognostic relevance in early-stage disease remains unclear. This study aimed to evaluate the prognostic value of baseline lymphopenia in patients with non-metastatic BC using data from the prospective French CANTO cohort (NCT01993498).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>10,854 patients with baseline absolute lymphocyte count (ALC) were analysed. Lymphopenia was defined as ALC\u2009&lt;\u20091.0\u2009\u00d7\u200910\u2079 cells\/L, measured before any cancer treatment. Relapse-free survival (RFS), overall survival (OS), and treatment-related toxicities were assessed using Kaplan-Meier estimates, piecewise-Cox regression models, and cause-specific hazard analyses considering pre-specified time periods.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Baseline lymphopenia was observed in 342 patients (3.1%). It was associated with ECOG performance status\u2009&gt;\u20090, hypoalbuminemia, and prior neoplasia. Lymphopenia correlated with inferior 5-year RFS (89.1% vs. 92.9%) and OS (92.5% vs. 96.4%). In multivariable analyses, lymphopenia was associated with increased risk of early relapse during the first 24 months (HR\u2009=\u20092.11; 95%CI: 1.28\u20133.48; p\u2009=\u20090.003), but not beyond, and no independent prognostic impact on OS was observed. No significant differences were found in surgical complications or chemotherapy dose intensity, though granulocyte colony-stimulating factor use was higher among lymphopenic patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Baseline lymphopenia is uncommon in early BC but may serve as a marker of early relapse risk. Although it does not independently predict long-term survival, its presence could reflect underlying tumour aggressiveness or patient frailty. These findings support further investigation of lymphocyte subpopulations to refine prognostic stratification in early BC.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration<\/jats:title>\n                    <jats:p>Approved by French ethics committee in 2011 (ID-RCB:2011-A01095- 36,11\u2013039 \/NCT01993498 [20FEB2012]).<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13058-026-02315-7","type":"journal-article","created":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T12:55:07Z","timestamp":1781009707000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Prognostic value of lymphopenia in early breast cancer: learnings from the prospective CANTO cohort"],"prefix":"10.1186","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1292-6631","authenticated-orcid":false,"given":"St\u00e9phane","family":"Vignot","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youenn","family":"Drouet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Di Meglio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Laure","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Gaudin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aur\u00e9lie","family":"Bertaut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marion","family":"Fournier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Jacot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Cheymol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Kieffer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carole","family":"Tarpin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florence","family":"Lerebours","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Caux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandrine","family":"Boyault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"M\u00e9n\u00e9trier-Caux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Tr\u00e9dan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,9]]},"reference":[{"key":"2315_CR1","doi-asserted-by":"crossref","unstructured":"Breast, Cancer\u2014Epidemiology. Risk Factors, Classification, Prognostic Markers, and Current Treatment Strategies\u2014An Updated Review [Internet]. [cited 2025 Mar 13]. Available from: https:\/\/www.mdpi.com\/2072-6694\/13\/17\/4287","DOI":"10.3390\/cancers13174287"},{"issue":"22","key":"2315_CR2","doi-asserted-by":"publisher","first-page":"5047","DOI":"10.1158\/1078-0432.CCR-15-0685","volume":"21","author":"L Mart\u00ednez-Lostao","year":"2015","unstructured":"Mart\u00ednez-Lostao L, Anel A, Pardo J. How Do Cytotoxic Lymphocytes Kill Cancer Cells? Clin Cancer Res. 2015;21(22):5047\u201356. https:\/\/doi.org\/10.1158\/1078-0432.CCR-15-0685.","journal-title":"Clin Cancer Res"},{"issue":"5","key":"2315_CR3","first-page":"1080","volume":"49","author":"J P\u00e9ron","year":"2013","unstructured":"P\u00e9ron J, Cropet C, Tredan O, Bachelot T, Ray-Coquard I, Clapisson G, et al. CD4 lymphopenia to identify end-of-life metastatic cancer patients. Eur J Cancer Oxf Engl 1990. 2013;49(5):1080\u20139. .003 PubMed PMID: 23246297.","journal-title":"Eur J Cancer Oxf Engl 1990"},{"key":"2315_CR4","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.radonc.2005.06.004","volume":"76","author":"L Claude","year":"2005","unstructured":"Claude L, Perol D, Ray Coquard I, Lymphopenia, et al. A new independent prognostic factor for survival in patients treated with whole brain radiotherapy for brain metastases from breast carcinoma. Radiother Oncol. 2005;76:334\u20139.","journal-title":"Radiother Oncol"},{"issue":"7","key":"2315_CR5","first-page":"1673","volume":"49","author":"O Tr\u00e9dan","year":"2013","unstructured":"Tr\u00e9dan O, Manuel M, Clapisson G, Bachelot T, Chabaud S, Bardin-dit-Courageot C, et al. Patients with metastatic breast cancer leading to CD4\u2009+\u2009T cell lymphopaenia have poor outcome. Eur J Cancer Oxf Engl 1990. 2013;49(7):1673\u201382. .028 PubMed PMID: 23265706.","journal-title":"Eur J Cancer Oxf Engl 1990"},{"issue":"5","key":"2315_CR6","doi-asserted-by":"publisher","first-page":"e000562","DOI":"10.1136\/esmoopen-2019-000562","volume":"4","author":"I Vaz-Luis","year":"2019","unstructured":"Vaz-Luis I, Cottu P, Mesleard C, Martin AL, Dumas A, Dauchy S, et al. UNICANCER: French prospective cohort study of treatment-related chronic toxicity in women with localised breast cancer (CANTO). ESMO Open. 2019;4(5):e000562. https:\/\/doi.org\/10.1136\/esmoopen-2019-000562 . PubMed PMID: 31555487; PubMed Central PMCID: PMC6735667.","journal-title":"ESMO Open"},{"key":"2315_CR7","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s12935-020-1094-5","volume":"20","author":"J Zhao","year":"2020","unstructured":"Zhao J, Huang W, Wu Y, Luo Y, Wu B, Cheng J, et al. Prognostic role of pretreatment blood lymphocyte count in patients with solid tumors: a systematic review and meta-analysis. Cancer Cell Int. 2020;20:15. https:\/\/doi.org\/10.1186\/s12935-020-1094-5 . PubMed PMID: 31938023; PubMed Central PMCID: PMC6954501.","journal-title":"Cancer Cell Int"},{"issue":"1","key":"2315_CR8","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/s40425-019-0549-5","volume":"7","author":"C M\u00e9n\u00e9trier-Caux","year":"2019","unstructured":"M\u00e9n\u00e9trier-Caux C, Ray-Coquard I, Blay JY, Caux C. Lymphopenia in Cancer Patients and its Effects on Response to Immunotherapy: an opportunity for combination with Cytokines? J Immunother Cancer. 2019;7(1):85. https:\/\/doi.org\/10.1186\/s40425-019-0549-5 . PubMed PMID: 30922400; PubMed Central PMCID: PMC6437964.","journal-title":"J Immunother Cancer"},{"issue":"2","key":"2315_CR9","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1007\/BF01807163","volume":"41","author":"R Demicheli","year":"1996","unstructured":"Demicheli R, Abbattista A, Miceli R, Valagussa P, Bonadonna G. Time distribution of the recurrence risk for breast cancer patients undergoing mastectomy: further support about the concept of tumor dormancy. Breast Cancer Res Treat. 1996;41(2):177\u201385. doi:10.1007\/BF01807163 PubMed PMID: 8944336.","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"2315_CR10","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/s10549-008-0291-z","volume":"117","author":"J Mansell","year":"2009","unstructured":"Mansell J, Monypenny IJ, Skene AI, Abram P, Carpenter R, Gattuso JM, et al. Patterns and predictors of early recurrence in postmenopausal women with estrogen receptor-positive early breast cancer. Breast Cancer Res Treat. 2009;117(1):91\u20138. https:\/\/doi.org\/10.1007\/s10549-008-0291-z . PubMed PMID: 19112615.","journal-title":"Breast Cancer Res Treat"},{"issue":"434","key":"2315_CR11","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1080\/01621459.1996.10476908","volume":"91","author":"DB Rubin","year":"1996","unstructured":"Rubin DB. Multiple Imputation after 18\u2009+\u2009Years. J Am Stat Assoc. 1996;91(434):473\u201389. https:\/\/doi.org\/10.1080\/01621459.1996.10476908.","journal-title":"J Am Stat Assoc"},{"key":"2315_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v070.i01","volume":"70","author":"J Josse","year":"2016","unstructured":"Josse J, Husson F, missMDA:. A Package for Handling Missing Values in Multivariate Data Analysis. J Stat Softw. 2016;70:1\u201331. https:\/\/doi.org\/10.18637\/jss.v070.i01.","journal-title":"J Stat Softw"},{"issue":"15","key":"2315_CR13","doi-asserted-by":"publisher","first-page":"1982","DOI":"10.1002\/sim.3618","volume":"28","author":"IR White","year":"2009","unstructured":"White IR, Royston P. Imputing missing covariate values for the Cox model. Stat Med. 2009;28(15):1982\u201398. 10. 1002\/sim.3618 PubMed PMID: 19452569; PubMed Central PMCID: PMC2998703.","journal-title":"Stat Med"},{"key":"2315_CR14","doi-asserted-by":"publisher","unstructured":"Therneau TM, Grambsch PM. Modeling Survival Data: Extending the Cox Model [Internet]. New York, NY: Springer; 2000 [cited 2025 Mar 13]. (Dietz K, Gail M, Krickeberg K, Samet J, Tsiatis A, editors. Statistics for Biology and Health). Available from: http:\/\/link.springer.com\/https:\/\/doi.org\/10.1007\/978-1-4757-3294-8 doi:10.1007\/978-1-4757-3294-8.","DOI":"10.1007\/978-1-4757-3294-8"},{"issue":"6","key":"2315_CR15","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1161\/CIRCULATIONAHA.115.017719","volume":"133","author":"PC Austin","year":"2016","unstructured":"Austin PC, Lee DS, Fine JP. Introduction to the Analysis of Survival Data in the Presence of Competing Risks. Circulation. 2016;133(6):601\u20139. 10.1161. \/CIRCULATIONAHA.115.017719 PubMed PMID: 26858290; PubMed Central PMCID: PMC4741409.","journal-title":"Circulation"},{"issue":"11","key":"2315_CR16","doi-asserted-by":"publisher","first-page":"e0312540","DOI":"10.1371\/journal.pone.0312540","volume":"19","author":"W Xie","year":"2024","unstructured":"Xie W, Ji L, Kang L, Li Q, Luo D, He Q, et al. Prevalence of lymphopenia in the American population: Insights from demographic, BMI, and lifestyle factors. PLoS ONE. 2024;19(11):e0312540. https:\/\/doi.org\/10.1371\/journal.pone.0312540 . PubMed PMID: 39495758; PubMed Central PMCID: PMC11534243.","journal-title":"PLoS ONE"},{"issue":"4","key":"2315_CR17","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1016\/j.breast.2011.11.002","volume":"21","author":"MA Vicente Conesa","year":"2012","unstructured":"Vicente Conesa MA, Garcia-Martinez E, Gonzalez Billalabeitia E, Chaves Benito A, Garcia Garcia T, Vicente Garcia V, et al. Predictive value of peripheral blood lymphocyte count in breast cancer patients treated with primary chemotherapy. Breast Edinb Scotl. 2012;21(4):468\u201374. PubMed PMID: 22119767.","journal-title":"Breast Edinb Scotl"},{"key":"2315_CR18","doi-asserted-by":"publisher","first-page":"viii62","DOI":"10.1093\/annonc\/mdy270.191","volume":"29","author":"GM Kim","year":"2018","unstructured":"Kim GM, Koh HD, Kim JH, Park BW, Cho YU, Kim SI, et al. Baseline lymphocyte counts predict distant recurrence in early breast cancer. Ann Oncol. 2018;29:viii62\u20133. https:\/\/doi.org\/10.1093\/annonc\/mdy270.191 . PubMed PMID: 32137667.","journal-title":"Ann Oncol"},{"key":"2315_CR19","doi-asserted-by":"publisher","first-page":"110390","DOI":"10.1016\/j.radonc.2024.110390","volume":"199","author":"YC Song","year":"2024","unstructured":"Song YC, Chen SY, Zhao XR, Jing H, Fang H, Tang Y, et al. Prognostic value of lymphocytes in patients with breast cancer receiving radiotherapy after breast-conserving surgery: A post hoc analysis of a phase III randomized trial. Radiother Oncol J Eur Soc Ther Radiol Oncol. 2024;199:110390. https:\/\/doi.org\/10.1016\/j.radonc.2024.110390 . PubMed PMID: 38897316.","journal-title":"Radiother Oncol J Eur Soc Ther Radiol Oncol"},{"issue":"1","key":"2315_CR20","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/bjc","volume":"55","author":"CW Pattison","year":"1987","unstructured":"Pattison CW, Woods KL, Morrison JM. Lymphocytopenia as an independent predictor of early recurrence in breast cancer. Br J Cancer. 1987;55(1):75\u20136. https:\/\/doi.org\/10.1038\/bjc. 1987.15 PubMed PMID: 3814479; PubMed Central PMCID: PMC2001556.","journal-title":"Br J Cancer"},{"issue":"4","key":"2315_CR21","doi-asserted-by":"publisher","first-page":"958","DOI":"10.3390\/cancers12040958","volume":"12","author":"I Corbeau","year":"2020","unstructured":"Corbeau I, Jacot W, Guiu S. Neutrophil to Lymphocyte Ratio as Prognostic and Predictive Factor in Breast Cancer Patients: A Systematic Review. Cancers. 2020;12(4):958. doi:10.3390\/cancers12040958 PubMed PMID: 32295078; PubMed Central PMCID: PMC7226461.","journal-title":"Cancers"},{"issue":"9","key":"2315_CR22","doi-asserted-by":"publisher","first-page":"3609","DOI":"10.1172\/JCI45816","volume":"121","author":"E Mamessier","year":"2011","unstructured":"Mamessier E, Sylvain A, Thibult ML, Houvenaeghel G, Jacquemier J, Castellano R, et al. Human breast cancer cells enhance self tolerance by promoting evasion from NK cell antitumor immunity. J Clin Invest. 2011;121(9):3609\u201322. https:\/\/doi.org\/10.1172\/JCI45816 . PubMed PMID: 21841316; PubMed Central PMCID: PMC3171102.","journal-title":"J Clin Invest"},{"issue":"3","key":"2315_CR23","doi-asserted-by":"publisher","first-page":"e1100791","DOI":"10.1080\/2162402X.2015.1100791","volume":"5","author":"E Verron\u00e8se","year":"2016","unstructured":"Verron\u00e8se E, Delgado A, Valladeau-Guilemond J, Garin G, Guillemaut S, Tredan O, et al. Immune cell dysfunctions in breast cancer patients detected through whole blood multi-parametric flow cytometry assay. Oncoimmunology. 2016;5(3):e1100791. PubMed PMID: 27141361; PubMed Central PMCID: PMC4839376.","journal-title":"Oncoimmunology"},{"issue":"2","key":"2315_CR24","doi-asserted-by":"publisher","first-page":"e1108","DOI":"10.1002\/cti2","volume":"9","author":"RN Ramos","year":"2020","unstructured":"Ramos RN, Rodriguez C, Hubert M, Ardin M, Treilleux I, Ries CH, et al. CD163\u2009+\u2009tumor-associated macrophage accumulation in breast cancer patients reflects both local differentiation signals and systemic skewing of monocytes. Clin Transl Immunol. 2020;9(2):e1108. https:\/\/doi.org\/10.1002\/cti2. 1108 PubMed PMID: 32082570; PubMed Central PMCID: PMC7017151.","journal-title":"Clin Transl Immunol"},{"issue":"4","key":"2315_CR25","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1016\/s0959-8049","volume":"39","author":"V Ivanovi\u0107","year":"2003","unstructured":"Ivanovi\u0107 V, Todorovi\u0107-Rakovi\u0107 N, Demajo M, Neskovi\u0107-Konstantinovi\u0107 Z, Subota V, Ivanisevi\u0107-Milovanovi\u0107 O, et al. Elevated plasma levels of transforming growth factor-beta 1 (TGF-beta 1) in patients with advanced breast cancer: association with disease progression. Eur J Cancer Oxf Engl 1990. 2003;39(4):454\u201361. https:\/\/doi.org\/10.1016\/s0959-8049. (02)00502-6 PubMed PMID: 12751375.","journal-title":"Eur J Cancer Oxf Engl 1990"},{"issue":"11","key":"2315_CR26","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1038\/sj.bjc.6600956","volume":"88","author":"T Bachelot","year":"2003","unstructured":"Bachelot T, Ray-Coquard I, Menetrier-Caux C, Rastkha M, Duc A, Blay JY. Prognostic value of serum levels of interleukin 6 and of serum and plasma levels of vascular endothelial growth factor in hormone-refractory metastatic breast cancer patients. Br J Cancer. 2003;88(11):1721\u20136. https:\/\/doi.org\/10.1038\/sj.bjc.6600956 . PubMed PMID: 12771987; PubMed Central PMCID: PMC2377148.","journal-title":"Br J Cancer"},{"issue":"6","key":"2315_CR27","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1530\/ERC-13-0198","volume":"20","author":"S Aharinejad","year":"2013","unstructured":"Aharinejad S, Salama M, Paulus P, Zins K, Berger A, Singer CF. Elevated CSF1 serum concentration predicts poor overall survival in women with early breast cancer. Endocr Relat Cancer. 2013;20(6):777\u201383. https:\/\/doi.org\/10.1530\/ERC-13-0198 . PubMed PMID: 24016870.","journal-title":"Endocr Relat Cancer"},{"issue":"4","key":"2315_CR28","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1002\/ajh.10363","volume":"73","author":"CW Choi","year":"2003","unstructured":"Choi CW, Sung HJ, Park KH, Yoon SY, Kim SJ, Oh SC, et al. Early lymphopenia as a risk factor for chemotherapy-induced febrile neutropenia. Am J Hematol. 2003;73(4):263\u20136. https:\/\/doi.org\/10.1002\/ajh.10363 . PubMed PMID: 12879430.","journal-title":"Am J Hematol"},{"key":"2315_CR29","doi-asserted-by":"publisher","first-page":"2675","DOI":"10.1002\/cncr.20688","volume":"101","author":"C Borg","year":"2004","unstructured":"Borg C, Ray Coquard I, Philip I, et al. CD4 lymphopenia as a risk factor for febrile neutropenia and early death after cytotoxic chemotherapy in adult patients with cancer. Cancer. 2004;101:2675\u201380.","journal-title":"Cancer"},{"issue":"14","key":"2315_CR30","doi-asserted-by":"publisher","first-page":"3299","DOI":"10.3390\/cancers14143299","volume":"14","author":"S Kasimir-Bauer","year":"2022","unstructured":"Kasimir-Bauer S, Karaaslan E, Hars O, Hoffmann O, Kimmig R. In Early Breast Cancer, the Ratios of Neutrophils, Platelets and Monocytes to Lymphocytes Significantly Correlate with the Presence of Subsets of Circulating Tumor Cells but Not with Disseminated Tumor Cells. Cancers. 2022;14(14):3299. https:\/\/doi.org\/10.3390\/cancers14143299 . PubMed PMID: 35884360; PubMed Central PMCID: PMC9320225.","journal-title":"Cancers"},{"issue":"8","key":"2315_CR31","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1056\/NEJM200002243420801","volume":"342","author":"S Braun","year":"2000","unstructured":"Braun S, Pantel K, M\u00fcller P, Janni W, Hepp F, Kentenich CR, et al. Cytokeratin-positive cells in the bone marrow and survival of patients with stage I, II, or III breast cancer. N Engl J Med. 2000;342(8):525\u201333. doi:10.1056\/NEJM200002243420801 PubMed PMID: 10684910.","journal-title":"N Engl J Med"},{"issue":"8","key":"2315_CR32","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1056\/NEJMoa050434","volume":"353","author":"S Braun","year":"2005","unstructured":"Braun S, Vogl FD, Naume B, Janni W, Osborne MP, Coombes RC, et al. A pooled analysis of bone marrow micrometastasis in breast cancer. N Engl J Med. 2005;353(8):793\u2013802. doi:10.1056\/NEJMoa050434 PubMed PMID: 16120859.","journal-title":"N Engl J Med"}],"container-title":["Breast Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13058-026-02315-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13058-026-02315-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13058-026-02315-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T23:50:52Z","timestamp":1786665052000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13058-026-02315-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,9]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2315"],"URL":"https:\/\/doi.org\/10.1186\/s13058-026-02315-7","relation":{},"ISSN":["1465-542X"],"issn-type":[{"value":"1465-542X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,9]]},"assertion":[{"value":"28 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"According to French regulations, CANTO was approved by French ethics committee in 2011 (ID-RCB:2011-A01095- 36,11\u2013039). The trial is being performed in accordance with the Declaration of Helsinki. All patients enrolled in the study provide written informed consent.","order":1,"name":"Ethics","label":"Human Ethics and Consent to Participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for Publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"143"}}